
Cosmochemistry techniques shed light on potential new Alzheimer’s disease biomarker
The study identifies lower potassium isotope ratios in Alzheimer’s patients, suggesting δ41K as a viable biomarker for early detection of the disease.
The study identifies lower potassium isotope ratios in Alzheimer’s patients, suggesting δ41K as a viable biomarker for early detection of the disease.
Share
Facebook
X
LinkedIn
Telegram
Tumblr
Whatsapp
VK
Mail